The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries (LMICs). Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with patent holders for thirteen HIV antiretrovirals, three hepatitis C direct-acting antivirals, a tuberculosis treatment and recently for COVID-19 drugs and technology. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC). MPP is funded as well by various public funders for its work on mRNA program.

More about MPP

The Expert Advisory Group has a consultative function. Its role as per MPP’s Statues and By-Laws is to:

• Review and provide advice to the Governance Board and the MPP’s Executive Director, upon request, with regard to general strategy and key management decisions;
• Provide a written report containing EAG’s recommendations to the Governance Board on the specifics of each licence agreement, which report will be submitted to the Board and ultimately published in the MPP web page, should the proposed agreement proceed to execution.

More information on the role of EAG and its Terms of Reference are available here

MPP is looking for an individual with expertise in the science of and research & development into vaccines and biologics. -The ideal candidate will also have a good understanding of the public health issues in LMICs as well as of the MPP model to improve access to affordable and appropriate essential medicines in LMICs.

EAG members serve in their personal capacity and on an unremunerated basis. EAG members have to abide by MPP general policies. More on MPP policies.

EAG members serve a three-year term renewable once. EAG meetings are normally convened once a year in person (all expenses paid) and teleconferences are organised in between as required according to MPP’s needs.

To apply, please complete the application form by 31 May 2025, providing your CV and a cover letter outlining your relevant experience, expertise, and interest in joining our EAG.

You may also nominate a candidate by completing the same application form and providing the required details.

The Medicines Patent Pool (MPP) management will compile a list of suitable candidates for initial review by the Governance Board. Interviews may be conducted prior to a final Board decision. MPP is committed to achieving gender balance (50/50) and geographical diversity within its EAG.

To apply, please use the “Apply Job” button at the top of this page.